Aspirin Attenuates Pulmonary Arterial Hypertension in Rats by Reducing Plasma 5-Hydroxytryptamine Levels
Authors:
- 15 February 2011
- journal article
- Published by Springer Nature in Cell Biochemistry and Biophysics
- Vol. 61 (1) , 23-31
Abstract
Pulmonary arterial hypertension (PAH) is characterized by increasing pulmonary pressure, right ventricular failure, and death. The typical pathological changes include medial hypertrophy, intimal fibrosis and in situ thrombosis. Serotonin (5-HT) and other factors contribute to the development of pathologic lesions. Aspirin (ASA), a platelet aggregation inhibitor, inhibits 5-HT release from platelets. The aim of this study was to determine the efficacy of ASA in preventing or attenuating PAH. Sprague–Dawley rats injected with monocrotaline (MCT) developed severe PAH within 31 days. One hundred forty rats were randomized to receive either vehicle or ASA (0.5, 1, 2, or 4 mg/kg/day). The pre-ASA group was treated with ASA (1 mg/kg/day) for 30 days before the MCT injection. Thirty-one days after the injection (day 61 for the pre-ASA group), pulmonary arterial pressure (PAP), right ventricular hypertrophy and pulmonary arteriole thickness were measured. Plasma 5-HT was measured by high-performance liquid chromatography. Aspirin suppressed PAH and increased the survival rate compared with the control group (84 vs. 60%, P < 0.05). Aspirin treatment also reduced right ventricular hypertrophy and pulmonary arteriole proliferation in ASA-treated PAH model. In addition, plasma 5-HT was decreased in our ASA-treated PAH model. The degree of 5-HT reduction was associated with systolic PAP, right ventricular hypertrophy and wall thickness of pulmonary arterioles in rats. These results showed that ASA treatment effectively attenuated MCT-induced pulmonary hypertension, right ventricular hypertrophy, and occlusion of the pulmonary arteries. The effects of ASA was associated with a reduction of 5-HT.Keywords
This publication has 22 references indexed in Scilit:
- Pulmonary Hemodynamic Response to Acute Combination and Monotherapy With Sildenafil and Brain Natriuretic Peptide in Rats With Monocrotaline-Induced Pulmonary HypertensionThe American Journal of the Medical Sciences, 2010
- In vivo effects of a combined 5-HT1B receptor/SERT antagonist in experimental pulmonary hypertensionCardiovascular Research, 2009
- Characterization of a murine model of monocrotaline pyrrole-induced acute lung injuryBMC Pulmonary Medicine, 2008
- Smad Signaling in the Rat Model of Monocrotaline Pulmonary HypertensionToxicologic Pathology, 2008
- Pathology of Pulmonary HypertensionClinics in Chest Medicine, 2007
- Transgenic Mice Overexpressing the 5-Hydroxytryptamine Transporter Gene in Smooth Muscle Develop Pulmonary HypertensionCirculation Research, 2006
- A study of aspirin and clopidogrel in idiopathic pulmonary arterial hypertensionEuropean Respiratory Journal, 2006
- Serotonin Transporter Inhibition Prevents and Reverses Monocrotaline-Induced Pulmonary Hypertension in RatsCirculation, 2005
- Pulmonary Arterial HypertensionCirculation, 2004
- Chronic pulmonary hypertension‐the monocrotaline model and involvement of the hemostatic systemJournal of Toxicology and Environmental Health, Part B, 1998